Search for stocks /

Godrej Agrovet Ltd Q2FY26: EBITDA up 10%, PAT down 17%, SEBI warning letter, new CEO—agriculture meets corporate drama


1. At a Glance

Welcome to Godrej Agrovet Limited (GAVL) — India’s agri-conglomerate that milks cows, breeds chickens, squeezes oil palms, sprays crops, and somehow still has time to deal with SEBI warning letters. At ₹ 649 per share, the company commands a market cap of ₹ 12,485 crore, but the recent 20% price fall in 3 months feels like watching your tractor slide on wet mud.

In Q2 FY26, revenue stood at ₹ 2,567 crore (+4.85% YoY), but PAT dropped 17.6% to ₹ 92.6 crore. Operating margins held at 8%, ROE 17.7%, and ROCE 16.6%. The balance sheet is stretched tighter than a farmer’s budget before harvest — debt rose from ₹ 1,400 crore to ₹ 1,923 crore as of Sep 2025.

Still, Godrej Agrovet isn’t your average mandi-trader. It’s the rare agribusiness that also throws a boardroom party when EBITDA margins touch 9%. But with the SEBI’s warning for delayed disclosures and a new CEO in the hot seat, the next quarter promises as much drama as a daily soap titled Khaad, Cow & Corporate Karma.


2. Introduction

Godrej Agrovet is that overachieving cousin in the Godrej family—busy running five different agribusinesses while juggling government MoUs, dairy expansions, and now, a SEBI slap on the wrist.

Founded on the noble mission of improving farmer productivity, it’s now a ₹ 10,000 crore+ machine operating from cattle feed to palm oil to pesticides to paneer. But despite its fancy R&D and premium Jersey milk ads, its stock performance has been as cold as that same Jersey milk left overnight.

In the past year, shareholders lost 10.5%, and in the last 3 months alone 20%. Meanwhile, management has been expanding into palm refineries, signing ₹ 960 crore MoUs, and bringing in a new CEO — Sunil Kataria, the ex-Godrej Consumer Products boss who knows a thing or two about turning soaps into gold.

The business is classic Godrej — heritage brand + R&D + diversification. But the real question: can this conglomerate balance milk, meat, and money without spilling any?


3. Business Model – WTF Do They Even Do?

If you ever wanted to invest in something that feeds cows, fattens chickens, crushes palm fruit, ferments milk, and sells pesticides — look no further. Godrej Agrovet is the buffet of Indian agribusiness.

Animal Feed (47%) – Their biggest revenue cow. They produce compound feed for cattle, poultry, fish, and shrimp. Even Bangladesh eats out of Godrej’s trough via their JV ACI Agrovet.

Dairy (17%) – Operated via Creamline Dairy Products under the Jersey brand, selling everything from curd to lassi. They recently hiked their stake to 99.3%, so Jersey is now a full Godrej cow.

Vegetable Oil (14%) – India’s largest oil-palm processor with 30% market share. Think of them as “the Adani Wilmar of the south but with trees.” They work with 11,000 farmers managing 2 lakh hectares of plantations.

Crop Protection (13%) – Via subsidiary Astec Lifesciences, they sell pesticides, fungicides, and regulators. Astec’s enterprise division had a bad year, proving that even chemicals can get depressed.

Poultry & Processed Foods (9%) – Their JV with Tyson Foods brings you Real Good Chicken and Yummiez, the products that confuse vegetarians and excite gym-goers.

Together, this makes GAVL an agricultural Swiss-army knife: diversified, complex, and dangerous in the wrong hands.


4. Financials Overview

MetricLatest Qtr (Sep FY26)Same Qtr Last YearPrevious QtrYoY %QoQ %
Revenue (₹ cr)2,5672,4492,614+4.8−1.8
EBITDA (₹ cr)213223270−4.5−21.1
PAT (₹ cr)92.6112149−17.6−37.8
EPS (₹)4.85.88.4−17.6−42.6

Annualized EPS ≈ ₹ 19.2 → P/E ≈ 34×.

Commentary: Revenue up, profits down — the classic Indian corporate diet. Input costs and flat realizations hit margins, and management called it “temporary.” Investors call it “permanent déjà vu.”


5. Valuation Discussion – Fair Value Range (Educational Only)

Let’s take three neutral lenses:

(a) P/E Method
EPS TTM = ₹ 22.6
Industry P/E = 19× (Agro-FMCG average)

  • Optimistic case: 22.6 × 30 = ₹ 678
  • Base case: 22.6 ×
Join 10,000+ investors who read this every week.
Become a member
error: Content is protected !!